YK-11 (Myostine) Capsules
$70.00
Among its other forms, such as liquid and injectable, capsules truly stand out. They are quick to absorb and digest in research settings.
As a Selective Androgen Receptor Modulator (SARM), YK-11 has demonstrated the potential to selectively bind to androgen receptors predominantly expressed in skeletal muscle and osseous tissues in non-clinical research models.
After binding, YK-11 capsules may mimic the effects of natural testosterone in subjects. This receptor-specific activity may contribute to the stimulation of myogenic pathways and support enhancements in bone mineral density in experimental settings.
Apart from that, they may also act as myostatin inhibitors in research subjects. Myostatin is a regulatory protein that negatively modulates myogenesis. Its inhibition has been associated with the potential promotion of skeletal muscle hypertrophy in preclinical studies.
Mechanism of Action of YK-11 SARM Capsule
YK-11 has the potential to selectively target androgen receptors in specific tissues, including skeletal muscle and osseous structures, in preclinical models. Upon binding, YK-11 may replicate the physiological effects of testosterone, thereby eliciting potential benefits such as promoting lean muscle accretion, enhancing bone mineral density, and influencing adipose tissue metabolism in research subjects.
Properties of YK11 (Myostine) Capsules
- Chemical Formula C25H34O6
- Synonym YK11, YK-11, Myostine, Mysotatine, YK11 CPD.
- IUPAC Name methyl (2E)-2-[(8R,9S,10R,13S,14S,17S)-2′-methoxy-2′,13-dimethyl-3-oxospiro[1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-17,5′-1,3-dioxolane]-4′-ylidene]acetate
- Molecular weight 430.5 g/mol
- CAS Number 1370003-76-1
- PubChem CID 119058028
- Shelf Life 36 months